Market Overview

Covidien Announces Continued Relationship with NYSE Euronext

Share:
Related COV
Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression
Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids
Related NYX
NYSE-ARCA Exchange Time Experiences Excessive Latency In May
What a Phone Call from My Aunt Told Me About the Stock Market

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt plc intends to apply to list its ordinary shares on the New York Stock Exchange (NYSE) to trade under the symbol MNK.

As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013.

Posted-In: News

 

Related Articles (COV + NYX)

View Comments and Join the Discussion!